On November 26, 2019 Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, reported that members of the management team will participate in the following investor conferences (Press release, Gossamer Bio, NOV 26, 2019, View Source [SID1234551724]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3 at 1:30 p.m. ET in New York
Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4 at 11:20 a.m. ET in Boston
A live webcast of the presentations will be available on the "Events and Presentations" page in the "Investors" section of the company’s website at View Source A replay of the webcast will be archived on the company’s website for 90 days following the presentation.